Medicine and Dentistry
Patient
100%
Atrial Fibrillation
73%
Atrial Flutter
51%
Inpatient
36%
Thromboembolism
34%
Cohort Analysis
34%
Follow up
33%
Death
26%
Catheter Ablation
25%
Vascular Disease
23%
Hazard Ratio
22%
Observational Study
18%
Niacin
17%
Exercise
17%
Laropiprant
17%
Anacetrapib
17%
Athletic Training
17%
Vein
17%
Persistent Atrial Fibrillation
17%
Randomized Controlled Trial
17%
Coronary Artery Bypass Surgery
17%
Quality of Life
17%
Systematic Review
17%
Disease Exacerbation
17%
Attitude
17%
Low Density Lipoprotein Cholesterol
15%
Ablation Therapy
15%
Pulmonary Vein Isolation
14%
High Density Lipoprotein Cholesterol
12%
Vein Graft
12%
Adverse Event
9%
Statin
9%
Incidence
9%
Mortality
8%
Antiarrhythmic Agent
8%
Invasive Procedure
8%
Graft Failure
8%
Age
8%
All Cause Mortality
8%
Myocardial Infarction
8%
Cardiac Dysrhythmia
7%
Heart Failure
7%
Prevalence
7%
Combination Therapy
7%
Mortality Rate
7%
Atrial Fibrillation Ablation
7%
Cardioversion
6%
Recurrent Disease
6%
Catheter
5%
Sinus Rhythm
5%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
34%
Vascular Disease
23%
Heart Atrium Flutter
17%
Thromboembolism
17%
Nicotinic Acid
17%
Low Density Lipoprotein Cholesterol
15%
High Density Lipoprotein Cholesterol
12%
Adverse Event
9%
Incidence
8%
Statin (Protein)
7%
